191 related articles for article (PubMed ID: 22093619)
1. Conformational epitopes of myelin oligodendrocyte glycoprotein are targets of potentially pathogenic antibody responses in multiple sclerosis.
Menge T; Lalive PH; von Büdingen HC; Genain CP
J Neuroinflammation; 2011 Nov; 8():161. PubMed ID: 22093619
[TBL] [Abstract][Full Text] [Related]
2. Antibodies to native myelin oligodendrocyte glycoprotein are serologic markers of early inflammation in multiple sclerosis.
Lalive PH; Menge T; Delarasse C; Della Gaspera B; Pham-Dinh D; Villoslada P; von Büdingen HC; Genain CP
Proc Natl Acad Sci U S A; 2006 Feb; 103(7):2280-5. PubMed ID: 16461459
[TBL] [Abstract][Full Text] [Related]
3. Commentary: Sorting the wheat from the chaff: identifying demyelinating components of the myelin oligodendrocyte glycoprotein (MOG)-specific autoantibody repertoire.
Mathey E; Breithaupt C; Schubart AS; Linington C
Eur J Immunol; 2004 Aug; 34(8):2065-71. PubMed ID: 15259003
[TBL] [Abstract][Full Text] [Related]
4. Relevant antibody subsets against MOG recognize conformational epitopes exclusively exposed in solid-phase ELISA.
Menge T; von Büdingen HC; Lalive PH; Genain CP
Eur J Immunol; 2007 Nov; 37(11):3229-39. PubMed ID: 17918203
[TBL] [Abstract][Full Text] [Related]
5. Identification of a pathogenic antibody response to native myelin oligodendrocyte glycoprotein in multiple sclerosis.
Zhou D; Srivastava R; Nessler S; Grummel V; Sommer N; Brück W; Hartung HP; Stadelmann C; Hemmer B
Proc Natl Acad Sci U S A; 2006 Dec; 103(50):19057-62. PubMed ID: 17142321
[TBL] [Abstract][Full Text] [Related]
6. Pathogenic myelin oligodendrocyte glycoprotein antibodies recognize glycosylated epitopes and perturb oligodendrocyte physiology.
Marta CB; Oliver AR; Sweet RA; Pfeiffer SE; Ruddle NH
Proc Natl Acad Sci U S A; 2005 Sep; 102(39):13992-7. PubMed ID: 16172404
[TBL] [Abstract][Full Text] [Related]
7. Antibodies against the myelin oligodendrocyte glycoprotein and the myelin basic protein in multiple sclerosis and other neurological diseases: a comparative study.
Reindl M; Linington C; Brehm U; Egg R; Dilitz E; Deisenhammer F; Poewe W; Berger T
Brain; 1999 Nov; 122 ( Pt 11)():2047-56. PubMed ID: 10545390
[TBL] [Abstract][Full Text] [Related]
8. Anti-MOG autoantibodies in Italian multiple sclerosis patients: specificity, sensitivity and clinical association.
Mantegazza R; Cristaldini P; Bernasconi P; Baggi F; Pedotti R; Piccini I; Mascoli N; La Mantia L; Antozzi C; Simoncini O; Cornelio F; Milanese C
Int Immunol; 2004 Apr; 16(4):559-65. PubMed ID: 15039386
[TBL] [Abstract][Full Text] [Related]
9. Antibody cross-reactivity between myelin oligodendrocyte glycoprotein and the milk protein butyrophilin in multiple sclerosis.
Guggenmos J; Schubart AS; Ogg S; Andersson M; Olsson T; Mather IH; Linington C
J Immunol; 2004 Jan; 172(1):661-8. PubMed ID: 14688379
[TBL] [Abstract][Full Text] [Related]
10. Role of pathogenic T cells and autoantibodies in relapse and progression of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis in LEW.1AV1 rats.
Matsumoto Y; Park IK; Hiraki K; Ohtani S; Kohyama K
Immunology; 2009 Sep; 128(1 Suppl):e250-61. PubMed ID: 19175799
[TBL] [Abstract][Full Text] [Related]
11. Chronic relapsing experimental autoimmune encephalomyelitis with a delayed onset and an atypical clinical course, induced in PL/J mice by myelin oligodendrocyte glycoprotein (MOG)-derived peptide: preliminary analysis of MOG T cell epitopes.
Kerlero de Rosbo N; Mendel I; Ben-Nun A
Eur J Immunol; 1995 Apr; 25(4):985-93. PubMed ID: 7737302
[TBL] [Abstract][Full Text] [Related]
12. Distinction and temporal stability of conformational epitopes on myelin oligodendrocyte glycoprotein recognized by patients with different inflammatory central nervous system diseases.
Mayer MC; Breithaupt C; Reindl M; Schanda K; Rostásy K; Berger T; Dale RC; Brilot F; Olsson T; Jenne D; Pröbstel AK; Dornmair K; Wekerle H; Hohlfeld R; Banwell B; Bar-Or A; Meinl E
J Immunol; 2013 Oct; 191(7):3594-604. PubMed ID: 24014878
[TBL] [Abstract][Full Text] [Related]
13. Epitope mapping of anti-myelin oligodendrocyte glycoprotein (MOG) antibodies in a mouse model of multiple sclerosis: microwave-assisted synthesis of the peptide antigens and ELISA screening.
Pacini G; Ieronymaki M; Nuti F; Sabatino G; Larregola M; Aharoni R; Papini AM; Rovero P
J Pept Sci; 2016 Jan; 22(1):52-8. PubMed ID: 26663200
[TBL] [Abstract][Full Text] [Related]
14. Recombinant forms of myelin antigens expressed on Chinese hamster ovary (CHO) cells as a tool for identification of autoantibodies in serum of multiple sclerosis patients.
Jaśkiewicz E; Michałowska-Wender G; Pyszczek A; Wender M
Folia Neuropathol; 2010; 48(1):45-8. PubMed ID: 20383810
[TBL] [Abstract][Full Text] [Related]
15. Epitope specificity of demyelinating monoclonal autoantibodies directed against the human myelin oligodendrocyte glycoprotein (MOG).
Brehm U; Piddlesden SJ; Gardinier MV; Linington C
J Neuroimmunol; 1999 Jun; 97(1-2):9-15. PubMed ID: 10408984
[TBL] [Abstract][Full Text] [Related]
16. Serum antibodies to 25 myelin oligodendrocyte glycoprotein epitopes in multiple sclerosis and neuromyelitis optica: clinical value for diagnosis and disease activity.
Xu Y; Zhang Y; Liu CY; Peng B; Wang JM; Zhang XJ; Li HF; Cui LY
Chin Med J (Engl); 2012 Sep; 125(18):3207-10. PubMed ID: 22964310
[TBL] [Abstract][Full Text] [Related]
17. Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders.
Mader S; Gredler V; Schanda K; Rostasy K; Dujmovic I; Pfaller K; Lutterotti A; Jarius S; Di Pauli F; Kuenz B; Ehling R; Hegen H; Deisenhammer F; Aboul-Enein F; Storch MK; Koson P; Drulovic J; Kristoferitsch W; Berger T; Reindl M
J Neuroinflammation; 2011 Dec; 8():184. PubMed ID: 22204662
[TBL] [Abstract][Full Text] [Related]
18. Serum levels of anti-myelin antibodies in relapsing-remitting multiple sclerosis patients during different phases of disease activity and immunomodulatory therapy.
Angelucci F; Mirabella M; Frisullo G; Caggiula M; Tonali PA; Batocchi AP
Dis Markers; 2005; 21(2):49-55. PubMed ID: 15920290
[TBL] [Abstract][Full Text] [Related]
19. Anti-MOG antibody: The history, clinical phenotype, and pathogenicity of a serum biomarker for demyelination.
Ramanathan S; Dale RC; Brilot F
Autoimmun Rev; 2016 Apr; 15(4):307-24. PubMed ID: 26708342
[TBL] [Abstract][Full Text] [Related]
20. The fine specificity of the myelin oligodendrocyte glycoprotein autoantibody response in patients with multiple sclerosis and normal healthy controls.
Haase CG; Guggenmos J; Brehm U; Andersson M; Olsson T; Reindl M; Schneidewind JM; Zettl UK; Heidenreich F; Berger T; Wekerle H; Hohlfeld R; Linington C
J Neuroimmunol; 2001 Mar; 114(1-2):220-5. PubMed ID: 11240035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
